Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Lawson, Victoria A ^a   Lumicisi, Brooke ^a   Welton, Jeremy ^a   Machalek, Dorothy ^a   Gouramanis, Katrina ^a   Klemm, Helen M ^a   Stewart, James D ^a   Masters, Colin L ^a   Hoke, David E ^c   Collins, Steven J ^a   Hill, Andrew F ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARAN SULFATE; MUTANT PROTEIN; NUCLEIC ACID; POLYANION; PRION PROTEIN; SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL LINE; CONTROLLED STUDY; DISEASE COURSE; MAMMAL; MOUSE; NONHUMAN; PRION; PRION DISEASE; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN DEFECT; PROTEIN FOLDING; PROTEIN FUNCTION; SULFATION; WILD TYPE; ANIMAL; CELL FREE SYSTEM; CHEMISTRY; GENETICS; METABOLISM; MUTATION; STATIC ELECTRICITY;

MAMMALIA; MURINAE;

ANIMALS; CELL LINE; CELL-FREE SYSTEM; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; MICE; MUTANT PROTEINS; MUTATION; NUCLEIC ACIDS; PRION DISEASES; PRIONS; PROTEIN FOLDING; STATIC ELECTRICITY; SULFATES;

EID: 77957896276     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012351     Document Type: Article

References (69)

1. Collins SJ, Lawson VA, Masters CL (2004) Transmissible spongiform encephalopathies. Lancet 363: 51-61.
2. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347.
3. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
4. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, et al. (1994) Cellfree formation of protease-resistant prion protein. Nature 370: 471-474.
5. Lucassen R, Nishina K, Supattapone S (2003) In vitro amplification of proteaseresistant prion protein requires free sulfhydryl groups. Biochemistry 42: 4127-4135.
6. Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810-813.
7. Castilla J, Saa P, Hetz C, Soto C (2005) In vitro generation of infectious scrapie prions. Cell 121: 195-206.
8. Caughey B, Baron GS (2006) Prions and their partners in crime. Nature 443: 803-810.
9. Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285: 14083-14087.
10. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, et al. (2004) Synthetic mammalian prions. Science 305: 673-676.
11. Deleault NR, Harris BT, Rees JR, Supattapone S (2007) From the Cover: Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A 104: 9741-9746.
12. Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 327: 1132-1135.
13. Adler V, Zeiler B, Kryukov V, Kascsak R, Rubenstein R, et al. (2003) Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro. J Mol Biol 332: 47-57.
14. Deleault NR, Lucassen RW, Supattapone S (2003) RNA molecules stimulate prion protein conversion. Nature 425: 717-720.
15. Derrington E, Gabus C, Leblanc P, Chnaidermann J, Grave L, et al. (2002) PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1. C R Acad Sci III 325: 17-23.
16. Gabus C, Auxilien S, Pechoux C, Dormont D, Swietnicki W, et al. (2001) The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J Mol Biol 307: 1011-1021.
17. Gabus C, Derrington E, Leblanc P, Chnaiderman J, Dormont D, et al. (2001) The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J Biol Chem 276: 19301-19309.
18. Nandi PK, Leclerc E, Nicole JC, Takahashi M (2002) DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid. J Mol Biol 322: 153-161.
19. Nandi PK, Nicole JC (2004) Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent. J Mol Biol 344: 827-837.
20. Proske D, Gilch S, Wopfner F, Schatzl HM, Winnacker EL, et al. (2002) Prionprotein-specific aptamer reduces PrPSc formation. Chembiochem 3: 717-725.
21. Critchley P, Kazlauskaite J, Eason R, Pinheiro TJ (2004) Binding of prion proteins to lipid membranes. Biochem Biophys Res Commun 313: 559-567.
22. Kazlauskaite J, Sanghera N, Sylvester I, Venien-Bryan C, Pinheiro TJ (2003) Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 42: 3295-3304.
23. Kazlauskaite J, Pinheiro TJ (2005) Aggregation and fibrillization of prions in lipid membranes. Biochem Soc Symp. pp 211-222.
24. Sanghera N, Pinheiro TJ (2002) Binding of prion protein to lipid membranes and implications for prion conversion. J Mol Biol 315: 1241-1256.
25. Lee KS, Caughey B (2007) A simplified recipe for prions. Proc Natl Acad Sci U S A 104: 9551-9552.
26. Hijazi N, Kariv-Inbal Z, Gasset M, Gabizon R (2005) PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J Biol Chem 280: 17057-17061.
27. Horonchik L, Tzaban S, Ben-Zaken O, Yedidia Y, Rouvinski A, et al. (2005) Heparan sulfate is a cellular receptor for purified infectious prions. J Biol Chem 280: 17062-17067.
28. Gabizon R, Meiner Z, Halimi M, Ben-Sasson SA (1993) Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. J Cell Physiol 157: 319-325.
29. Shyng SL, Lehmann S, Moulder KL, Harris DA (1995) Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J Biol Chem 270: 30221-30229.
30. Ben-Zaken O, Tzaban S, Tal Y, Horonchik L, Esko JD, et al. (2003) Cellular heparan sulfate participates in the metabolism of prions. J Biol Chem 278: 40041-40049.
31. Snow AD, Kisilevsky R, Willmer J, Prusiner SB, DeArmond SJ (1989) Sulfated glycosaminoglycans in amyloid plaques of prion diseases. Acta Neuropathol (Berl) 77: 337-342.
32. Snow AD, Wight TN, Nochlin D, Koike Y, Kimata K, et al. (1990) Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab Invest 63: 601-611.
33. Adjou KT, Simoneau S, Sales N, Lamoury F, Dormont D, et al. (2003) A novel generation of heparan sulfate mimetics for the treatment of prion diseases. J Gen Virol 84: 2595-2603.
34. Doh-ura K, Ishikawa K, Murakami-Kubo I, Sasaki K, Mohri S, et al. (2004) Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol 78: 4999-5006.
35. Bone I, Belton L, Walker AS, Darbyshire J (2008) Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK. Eur J Neurol 15: 458-464.
36. Parry A, Baker I, Stacey R, Wimalaratna S (2007) Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate. J Neurol Neurosurg Psychiatry 78: 733-734.
37. Wang F, Wang X, Yuan CG, Ma J. Generating a Prion with Bacterially Expressed Recombinant Prion Protein. Science.
38. Wong C, Xiong LW, Horiuchi M, Raymond L, Wehrly K, et al. (2001) Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. Embo J 20: 377-386.
39. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, et al. (2005) Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 280: 26873-26879.
40. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S. Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 49: 3928-3934.
41. Brazier MW, Lewis V, Ciccotosto GD, Klug GM, Lawson VA, et al. (2006) Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease. Brain Res Bull 68: 346-354.
42. Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, et al. (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. Embo J 15: 1255-1264.
43. Kovacic P, Draskovich CD, Pozos RS (2007) Unifying electrostatic mechanism for phosphates and sulfates in cell signaling. J Recept Signal Transduct Res 27: 433-443.
44. Kovacic P, Pozos RS, Draskovich CD (2007) Unifying electrostatic mechanism for receptor-ligand activity. J Recept Signal Transduct Res 27: 411-431.
45. Kovacic P (2008) Unifying electrostatic mechanism for metal cations in receptors and cell signaling. J Recept Signal Transduct Res 28: 153-161.
46. Morillas M, Vanik DL, Surewicz WK (2001) On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein. Biochemistry 40: 6982-6987.
47. Nishina K, Jenks S, Supattapone S (2004) Ionic strength and transition metals control PrPSc protease resistance and conversion-inducing activity. J Biol Chem 279: 40788-40794.
48. Gonzalez-Iglesias R, Pajares MA, Ocal C, Espinosa JC, Oesch B, et al. (2002) Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J Mol Biol 319: 527-540.
49. Warner RG, Hundt C, Weiss S, Turnbull JE (2002) Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem 277: 18421-18430.
50. Taubner LM, Bienkiewicz EA, Copie V, Caughey B (2009) Structure of the flexible amino terminal domain of prion protein bound to a sulfated glycan. J Mol Biol.
51. Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, et al. (1998) Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci U S A 95: 11667-11672.
52. Cappai R, Stewart L, Jobling MF, Thyer JM, White AR, et al. (1999) Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation. Biochemistry 38: 3280-3284.
53. Yin S, Pham N, Yu S, Li C, Wong P, et al. (2007) Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans. Proc Natl Acad Sci U S A 104: 7546-7551.
54. Manson JC, Barron R, Jamieson E, Baybutt H, Tuzi N, et al. (2000) A single amino acid alteration in murine PrP dramatically alters TSE incubation time. Arch Virol Suppl. pp 95-102.
55. Courageot MP, Daude N, Nonno R, Paquet S, Di Bari MA, et al. (2008) A cell line infectible by prion strains from different species. J Gen Virol 89: 341-347.
56. Lawson VA, Vella LJ, Stewart JD, Sharples RA, Klemm H, et al. (2008) Mouseadapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture. Int J Biochem Cell Biol 40: 2793-2801.
57. Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, et al. (2007) Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 211: 582-590.
58. Baeuerle PA, Huttner WB (1986) Chlorate-a potent inhibitor of protein sulfation in intact cells. Biochem Biophys Res Commun 141: 870-877.
59. Lehmann S, Harris DA (1996) Mutant and infectious prion proteins display common biochemical properties in cultured cells. J Biol Chem 271: 1633-1637.
60. Swietnicki W, Petersen RB, Gambetti P, Surewicz WK (1998) Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem 273: 31048-31052.
61. Tateishi J, Ohta M, Koga M, Sato Y, Kuroiwa Y (1979) Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann Neurol 5: 581-584.
62. Tateishi J (1996) Transmission of human prion diseases to rodents. Seminars in Virology 7: 175-180.
63. Moore RA, Herzog C, Errett J, Kocisko DA, Arnold KM, et al. (2006) Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation. Protein Sci 15: 609-619.
64. Safaiyan F, Kolset SO, Prydz K, Gottfridsson E, Lindahl U, et al. (1999) Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem 274: 36267-36273.
65. Papakonstantinou E, Karakiulakis G, Roth M, Verghese-Nikolakaki S, Dawson M, et al. (1999) Glycosaminoglycan analysis in brain stems from animals infected with the bovine spongiform encephalopathy agent. Arch Biochem Biophys 370: 250-257.
66. Christofinis GJ, Beale AJ (1968) Some biological characters of cell lines derived from normal rabbit kidney. J Pathol Bacteriol 95: 377-381.
67. Vilette D, Andreoletti O, Archer F, Madelaine MF, Vilotte JL, et al. (2001) Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci U S A 98: 4055-4059.
68. Lawson VA, Stewart JD, Masters CL (2007) Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain. J Gen Virol 88: 2905-2914.
69. Paquet S, Daude N, Courageot MP, Chapuis J, Laude H, et al. (2007) PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells. J Virol 81: 10786-10791.